Kwang H. Lee
Seoul, Republic of Korea
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 98 publications
Acetate- Versus Lactate-Buffered Crystalloids for Prevention of Post-ERCP Pancreatitis in Patients Without Access to Rectal NSAIDs: A Multicentre Double-Blind Randomized Trial.
Journal: United European gastroenterology journal
Published: May 12, 2026
Malignant epithelial states drive immune dysfunction in ampulla of Vater carcinoma.
Journal: Biomarker research
Published: March 30, 2026
Sex-specific prognostic value of triceps skinfold thickness and albumin in pancreatic cancer.
Journal: iScience
Published: September 24, 2025
Remimazolam Enables Faster Sedation Induction and Recovery Compared With Midazolam in Diagnostic Upper Gastrointestinal Endoscopy: A Multicenter Randomized Controlled Trial.
Journal: United European gastroenterology journal
Published: September 20, 2025
Prognostic Value of Pseudotime from Texture Parameters of [18F]fluorodeoxyglucose PET/CT in Resectable Pancreatic Ductal Adenocarcinoma.
Journal: Academic radiology
Published: August 21, 2025
Prognostic Significance of 18 F-FDG PET/CT Radiomics in Patients With Resectable Pancreatic Ductal Adenocarcinoma Undergoing Curative Surgery.
Journal: Clinical nuclear medicine
Published: July 05, 2024
Remimazolam versus midazolam for sedation in diagnostic upper gastrointestinal endoscopy: study protocol for a randomized controlled trial.
Journal: Trials
Published: February 22, 2024
Single-cell transcriptome analysis reveals subtype-specific clonal evolution and microenvironmental changes in liver metastasis of pancreatic adenocarcinoma and their clinical implications.
Journal: Molecular cancer
Published: February 20, 2024
Remimazolam, a novel drug, for safe and effective endoscopic sedation.
Journal: Clinical endoscopy
Published: February 07, 2024
Skeletal Muscle Index Changes on Locoregional Treatment Application After FOLFIRINOX and Survival in Pancreatic Cancer.
Journal: Journal of cachexia, sarcopenia and muscle
Published: January 23, 2024
Correction: Efficacy of GV1001 with gemcitabine/capecitabine in previously untreated patients with advanced pancreatic ductal adenocarcinoma having high serum eotaxin levels (KG4/2015): an open-label, randomised, Phase 3 trial.
Journal: British journal of cancer
Published: December 04, 2023
Last Updated: 09/26/2026